Monoclonal Antibodies Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Monoclonal Antibodies stocks.

Monoclonal Antibodies Stocks Recent News

Date Stock Title
May 3 TGTX TG Therapeutics: Less Room For Doubt About Briumvi
May 3 TGTX TG Therapeutics, Inc. (NASDAQ:TGTX) Q1 2024 Earnings Call Transcript
May 3 MGNX MacroGenics Announces Date of First Quarter 2024 Financial Results Conference Call
May 3 TGTX Rainbows and Unicorns: TG Therapeutics, Inc. (NASDAQ:TGTX) Analysts Just Became A Lot More Optimistic
May 3 TGTX Why TG Therapeutics Stock Was Rocketing Higher This Week
May 3 HALO How Novo-Catalent Deal Affects Halozyme (HALO)?
May 3 TGTX TG Therapeutics, Inc. (TGTX) Q1 2024 Earnings Call Transcript
May 3 ZYME Zymeworks Inc. (ZYME) Q1 2024 Earnings Call Transcript
May 2 ZYME Zymeworks files automatic mixed securities shelf
May 2 ZYME Zymeworks GAAP EPS of -$0.42 misses by $0.10, revenue of $10.03M misses by $6.4M
May 2 ZYME Zymeworks Provides Corporate Update and Reports First Quarter 2024 Financial Results
May 2 BCAB BioAtla: A Buried ADC Concern Gets Some New Life In 2024
May 2 TGTX TG Therapeutics First Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
May 2 TGTX TG Therapeutics Inc (TGTX) (Q1 2024) Earnings Call Transcript Highlights: Robust Revenue Growth ...
May 2 TGTX Q1 2024 TG Therapeutics Inc Earnings Call
May 1 ZYME Zymeworks Q1 2024 Earnings Preview
May 1 TGTX TG Therapeutics jumps as Q1 Briumvi sales top guidance
May 1 TGTX TG Therapeutics Inc (TGTX) Surpasses Revenue Estimates in Q1 2024, Despite Widening Net Loss
May 1 TGTX TG Therapeutics (TGTX) Reports Q1 Loss, Tops Revenue Estimates
May 1 TGTX TG Therapeutics GAAP EPS of -$0.07 misses by $0.03, revenue of $63.47M beats by $8.86M
Monoclonal Antibodies

Monoclonal antibodies (mAb or moAb) are antibodies that are made by identical immune cells that are all clones of a unique parent cell. Monoclonal antibodies can have monovalent affinity, in that they bind to the same epitope (the part of an antigen that is recognized by the antibody). In contrast, polyclonal antibodies bind to multiple epitopes and are usually made by several different plasma cell (antibody secreting immune cell) lineages. Bispecific monoclonal antibodies can also be engineered, by increasing the therapeutic targets of one single monoclonal antibody to two epitopes.

Browse All Tags